(BF-B) Brown-Forman - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1156372096
Stock: Spirits, Whiskey, Wine, Liqueurs
Total Rating 42
Risk 78
Buy Signal -0.76
| Risk 5d forecast | |
|---|---|
| Volatility | 36.7% |
| Relative Tail Risk | -5.81% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.89 |
| Alpha | -36.05 |
| Character TTM | |
|---|---|
| Beta | 0.204 |
| Beta Downside | 0.633 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.52% |
| CAGR/Max DD | -0.39 |
EPS (Earnings per Share)
Revenue
Description: BF-B Brown-Forman March 05, 2026
Brown-Forman Corporation (BF-B) produces and sells a range of alcoholic beverages, including spirits, wines, and ready-to-drink products. The company operates in the Distillers & Vintners sub-industry, a sector characterized by strong brand loyalty and diverse product portfolios.
BF-Bs product offerings include well-known brands such as Jack Daniels, Woodford Reserve, and Herradura. The companys business model involves manufacturing, bottling, and distributing its products globally, serving customers through a network of distributors, state governments, and direct sales to retailers and wholesalers. This multi-channel distribution approach is common in the alcoholic beverage industry.
Founded in 1870, Brown-Forman Corporation is headquartered in Louisville, Kentucky, and has a significant international presence across North America, Europe, and other regions. For a comprehensive analysis of BF-Bs financial performance and market position, further research on platforms like ValueRay is recommended.
Headlines to watch out for
- Global demand for Jack Daniels whiskey drives revenue growth
- Premium tequila brands Herradura and el Jimador expand market share
- Input costs for grains and barrels impact profit margins
- International expansion into emerging markets increases sales
- Regulatory changes in alcohol distribution affect profitability
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 807.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 2.18 > 1.0 |
| NWC/Revenue: 68.94% < 20% (prev 75.45%; Δ -6.51% < -1%) |
| CFO/TA 0.10 > 3% & CFO 861.0m > Net Income 807.0m |
| Net Debt (2.34b) to EBITDA (1.19b): 1.97 < 3 |
| Current Ratio: 2.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (472.6m) vs 12m ago -0.06% < -2% |
| Gross Margin: 59.46% > 18% (prev 0.59%; Δ 5887 % > 0.5%) |
| Asset Turnover: 47.91% > 50% (prev 50.12%; Δ -2.21% > 0%) |
| Interest Coverage Ratio: 10.61 > 6 (EBITDA TTM 1.19b / Interest Expense TTM 104.0m) |
Altman Z'' 6.28
| A: 0.33 (Total Current Assets 4.23b - Total Current Liabilities 1.53b) / Total Assets 8.30b |
| B: 0.61 (Retained Earnings 5.05b / Total Assets 8.30b) |
| C: 0.13 (EBIT TTM 1.10b / Avg Total Assets 8.19b) |
| D: 1.19 (Book Value of Equity 5.03b / Total Liabilities 4.22b) |
| Altman-Z'' Score: 6.28 = AAA |
Beneish M -2.88
| DSRI: 1.19 (Receivables 983.0m/855.0m, Revenue 3.92b/4.04b) |
| GMI: 1.00 (GM 59.46% / 59.31%) |
| AQI: 1.04 (AQ_t 0.36 / AQ_t-1 0.34) |
| SGI: 0.97 (Revenue 3.92b / 4.04b) |
| TATA: -0.01 (NI 807.0m - CFO 861.0m) / TA 8.30b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of BF-B shares?
As of March 11, 2026, the stock is trading at USD 25.40 with a total of 4,437,138 shares traded.
Over the past week, the price has changed by -8.87%, over one month by -14.29%, over three months by -15.62% and over the past year by -30.85%.
Over the past week, the price has changed by -8.87%, over one month by -14.29%, over three months by -15.62% and over the past year by -30.85%.
Is BF-B a buy, sell or hold?
Brown-Forman has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold BF-B.
- StrongBuy: 2
- Buy: 3
- Hold: 10
- Sell: 3
- StrongSell: 2
What are the forecasts/targets for the BF-B price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.1 | 14.6% |
| Analysts Target Price | 29.1 | 14.6% |
BF-B Fundamental Data Overview March 09, 2026
P/E Trailing = 14.7719
P/E Forward = 14.9477
P/S = 2.9925
P/B = 2.8304
P/EG = 4.4484
Revenue TTM = 3.92b USD
EBIT TTM = 1.10b USD
EBITDA TTM = 1.19b USD
Long Term Debt = 2.42b USD (from longTermDebt, last fiscal year)
Short Term Debt = 656.0m USD (from shortTermDebt, last quarter)
Debt = 2.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.34b USD (from netDebt column, last quarter)
Enterprise Value = 14.04b USD (11.70b + Debt 2.75b - CCE 402.0m)
Interest Coverage Ratio = 10.61 (Ebit TTM 1.10b / Interest Expense TTM 104.0m)
EV/FCF = 19.24x (Enterprise Value 14.04b / FCF TTM 730.0m)
FCF Yield = 5.20% (FCF TTM 730.0m / Enterprise Value 14.04b)
FCF Margin = 18.61% (FCF TTM 730.0m / Revenue TTM 3.92b)
Net Margin = 20.58% (Net Income TTM 807.0m / Revenue TTM 3.92b)
Gross Margin = 59.46% ((Revenue TTM 3.92b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 60.87% (prev 59.56%)
Tobins Q-Ratio = 1.69 (Enterprise Value 14.04b / Total Assets 8.30b)
Interest Expense / Debt = 0.95% (Interest Expense 26.0m / Debt 2.75b)
Taxrate = 15.24% (48.0m / 315.0m)
NOPAT = 934.9m (EBIT 1.10b * (1 - 15.24%))
Current Ratio = 2.77 (Total Current Assets 4.23b / Total Current Liabilities 1.53b)
Debt / Equity = 0.67 (Debt 2.75b / totalStockholderEquity, last quarter 4.08b)
Debt / EBITDA = 1.97 (Net Debt 2.34b / EBITDA 1.19b)
Debt / FCF = 3.21 (Net Debt 2.34b / FCF TTM 730.0m)
Total Stockholder Equity = 4.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.86% (Net Income 807.0m / Total Assets 8.30b)
RoE = 19.93% (Net Income TTM 807.0m / Total Stockholder Equity 4.05b)
RoCE = 17.05% (EBIT 1.10b / Capital Employed (Equity 4.05b + L.T.Debt 2.42b))
RoIC = 13.89% (NOPAT 934.9m / Invested Capital 6.73b)
WACC = 5.56% (E(11.70b)/V(14.45b) * Re(6.67%) + D(2.75b)/V(14.45b) * Rd(0.95%) * (1-Tc(0.15)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.05%
[DCF] Terminal Value 87.61% ; FCFF base≈651.6m ; Y1≈749.2m ; Y5≈1.05b
[DCF] Fair Price = 96.68 (EV 30.82b - Net Debt 2.34b = Equity 28.48b / Shares 294.6m; r=5.90% [WACC]; 5y FCF grow 17.56% → 2.90% )
EPS Correlation: 24.43 | EPS CAGR: 18.18% | SUE: 1.59 | # QB: 1
Revenue Correlation: -27.75 | Revenue CAGR: 1.75% | SUE: 1.52 | # QB: 1
EPS next Quarter (2026-07-31): EPS=0.38 | Chg7d=-0.016 | Chg30d=-0.015 | Revisions Net=+0 | Analysts=11
EPS next Year (2027-04-30): EPS=1.70 | Chg7d=-0.029 | Chg30d=-0.028 | Revisions Net=+1 | Growth EPS=-1.4% | Growth Revenue=+1.3%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.2% (Discount Rate 7.9% - Earnings Yield 6.8%)
[Growth] Growth Spread = -1.7% (Analyst -0.5% - Implied 1.2%)
P/E Forward = 14.9477
P/S = 2.9925
P/B = 2.8304
P/EG = 4.4484
Revenue TTM = 3.92b USD
EBIT TTM = 1.10b USD
EBITDA TTM = 1.19b USD
Long Term Debt = 2.42b USD (from longTermDebt, last fiscal year)
Short Term Debt = 656.0m USD (from shortTermDebt, last quarter)
Debt = 2.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.34b USD (from netDebt column, last quarter)
Enterprise Value = 14.04b USD (11.70b + Debt 2.75b - CCE 402.0m)
Interest Coverage Ratio = 10.61 (Ebit TTM 1.10b / Interest Expense TTM 104.0m)
EV/FCF = 19.24x (Enterprise Value 14.04b / FCF TTM 730.0m)
FCF Yield = 5.20% (FCF TTM 730.0m / Enterprise Value 14.04b)
FCF Margin = 18.61% (FCF TTM 730.0m / Revenue TTM 3.92b)
Net Margin = 20.58% (Net Income TTM 807.0m / Revenue TTM 3.92b)
Gross Margin = 59.46% ((Revenue TTM 3.92b - Cost of Revenue TTM 1.59b) / Revenue TTM)
Gross Margin QoQ = 60.87% (prev 59.56%)
Tobins Q-Ratio = 1.69 (Enterprise Value 14.04b / Total Assets 8.30b)
Interest Expense / Debt = 0.95% (Interest Expense 26.0m / Debt 2.75b)
Taxrate = 15.24% (48.0m / 315.0m)
NOPAT = 934.9m (EBIT 1.10b * (1 - 15.24%))
Current Ratio = 2.77 (Total Current Assets 4.23b / Total Current Liabilities 1.53b)
Debt / Equity = 0.67 (Debt 2.75b / totalStockholderEquity, last quarter 4.08b)
Debt / EBITDA = 1.97 (Net Debt 2.34b / EBITDA 1.19b)
Debt / FCF = 3.21 (Net Debt 2.34b / FCF TTM 730.0m)
Total Stockholder Equity = 4.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.86% (Net Income 807.0m / Total Assets 8.30b)
RoE = 19.93% (Net Income TTM 807.0m / Total Stockholder Equity 4.05b)
RoCE = 17.05% (EBIT 1.10b / Capital Employed (Equity 4.05b + L.T.Debt 2.42b))
RoIC = 13.89% (NOPAT 934.9m / Invested Capital 6.73b)
WACC = 5.56% (E(11.70b)/V(14.45b) * Re(6.67%) + D(2.75b)/V(14.45b) * Rd(0.95%) * (1-Tc(0.15)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.05%
[DCF] Terminal Value 87.61% ; FCFF base≈651.6m ; Y1≈749.2m ; Y5≈1.05b
[DCF] Fair Price = 96.68 (EV 30.82b - Net Debt 2.34b = Equity 28.48b / Shares 294.6m; r=5.90% [WACC]; 5y FCF grow 17.56% → 2.90% )
EPS Correlation: 24.43 | EPS CAGR: 18.18% | SUE: 1.59 | # QB: 1
Revenue Correlation: -27.75 | Revenue CAGR: 1.75% | SUE: 1.52 | # QB: 1
EPS next Quarter (2026-07-31): EPS=0.38 | Chg7d=-0.016 | Chg30d=-0.015 | Revisions Net=+0 | Analysts=11
EPS next Year (2027-04-30): EPS=1.70 | Chg7d=-0.029 | Chg30d=-0.028 | Revisions Net=+1 | Growth EPS=-1.4% | Growth Revenue=+1.3%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.2% (Discount Rate 7.9% - Earnings Yield 6.8%)
[Growth] Growth Spread = -1.7% (Analyst -0.5% - Implied 1.2%)